chartexchange

Kyverna Therapeutics to Present at the Jefferies London Healthcare Conference

GlobeNewswire Inc. | Nov 5, 2026 4:02 PM EST

EMERYVILLE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical immunology company pioneering transformative therapies for people with neurologic autoimmune diseases, today announced that company management will present at the Jefferies Global Healthcare Conference in London, United Kingdom on Thursday, November 19, 2026, at 10:00 am GMT.

Read original article